Physician profile
Alan M Reznik
NPI 1275539785
$8,547.48
in general payments reported to CMS, 2019-2025
8 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $1,021 · 2021: $1,219 · 2022: $812 · 2023: $1,241 · 2024: $1,848 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,738 · Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,738.08 |
| Food and Beverage | $224.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovative Medical Products, INC. | $7,632.36 | 2019-2025 | |
| Smith+Nephew, INC. | $435.84 | 2019-2024 | Intellio Link Werewolf |
| Depuy Synthes Sales INC. | $140.71 | 2019-2025 | Orthovisc, Monovisc, Speedtrap |
| Vericel Corporation | $114.55 | 2022-2024 | Maci |
| Allergan, INC. | $91.77 | 2021 | |
| Ferring Pharmaceuticals INC. | $68.56 | 2022-2025 | Euflexxa |
| Horizon Therapeutics Plc | $46.20 | 2020-2022 | |
| Medartis INC. | $17.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Reznik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.